highmark blue cross blue shield glp 1 coverage Formulary + Prescription highmark blue cross blue shield
Description
Find out more today.
Recent studies show that upwards of 70% of the population is overweight, and Nashville, TN ranks in
FDA-approved dual-mechanism oral medication
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
Some data suggests that a meaningful portion of weight lost on GLP-1 medications can come from lean mass
